Regenerative Medicine journal
Future Medicine Ltd announced today that its journal Regenerative Medicine (ISSN: 1746-0751) has been selected for coverage in MEDLINE®. Maintained by the U.S. National Library of Medicine®, MEDLINE (Medical Literature Analysis and Retrieval System Online) is a premier bibliographic database containing approximately 13 million references to journal articles in life sciences.
Regenerative Medicine Senior Editor, Stephen Minger (Director, Stem Cell Biology Laboratory, Wolfson Centre for Age Related Disease, King’s College London, UK) commented; “We are delighted that Regenerative Medicine has been accepted for coverage on MEDLINE so soon after its launch in 2006. Acceptance in this prominent database speaks not only to the importance of the field, but also to the incredibly high quality of the articles and features published to date. I would personally like to thank the outstanding editorial advisory board for their continuing support, and look forward to continuing the progress of this journal as the foremost vehicle for commentary and debate for the stem cells and regenerative medicine community.”
Elisa Manzotti, Editorial Director of Future Medicine commented; “We are delighted that Regenerative Medicine has been accepted by MEDLINE. The field of regenerative medicine and stem cell biology has become one of the hottest areas in contemporary science, and we are pleased with the recognition Regenerative Medicine, has already received.”
Ms Manzotti continued; “We would like to thank the journal’s Senior Editor, Dr Minger, for his encouragement as well as our outstanding Editorial Board for their input and guidance thus far. Together we hope to make Regenerative Medicine the pre-eminent, pioneering, international scientific publication in translational and cellular medicine.”
Regenerative Medicine is published bimonthly in print and online formats and offers review articles, primary research, editorials, technology reports, interviews, perspectives and a variety of added-value content. Rigorous peer review and rapid publication ensure that only the best quality and pertinent research is published in a timely manner.
Regenerative Medicine was also recently recognized by The Association of Learned and Professional Society Publishers as joint winner of the 2006 ALPSP/Charlesworth Award for Best New Journal. This prestigious international award is presented annually to the best new journal across a wide range of disciplines.
The National Library of Medicine MEDLINE selection process is managed by an advisory committee, the Literature Selection Technical Review Committee, composed of authorities knowledgeable in the field of biomedicine, such as physicians, researchers, educators, editors, health science librarians and historians, to review and recommend the journal titles NLM should index. MEDLINE is searchable for free using PubMed at http://pubmed.gov.
Access to Regenerative Medicine is also currently available via a free 30-day trial. To apply for your free trial please email info@futuremedicine.com quoting reference RMMLE and you will be sent username and password access.